HMGB1 and Cirrhosis: To evaluate the therapeutic effects of HMGB1 peptide, HMGB1 peptide was injected into mice twice a week for 4 weeks using CCl4-induced cirrhosis model mice (Fig. 1A), and serum biochemical tests and fibrosis accumulation were evaluated compared with the NS injection control group.